A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future Tập 27 Số 12 - Trang 87-97
Khashayar Esfahani, Liya Roudaia, Najwa Buhlaiga, Sonia V. del Rincón, Neha Papneja, Wilson H. Miller
Compared with previous standards of care (including chemotherapy, radiotherapy, and surgery), cancer immunotherapy has brought significant improvements for patients in terms of survival and quality of life. Immunotherapy has now firmly established itself as a novel pillar of cancer care, from the metastatic stage to the adjuvant and neoadjuvant settings in numerous cancer types. In this re...... hiện toàn bộ Immune Checkpoint Inhibitors in Cancer Therapy Tập 29 Số 5 - Trang 3044-3060
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini‐Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Kenneth V. Honn, Arutha Kulasinghe
The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monoclonal antibodies, targeting these immune checkpoint proteins have been utilized successfully in patients with metastatic melanoma, renal cell carcinoma, head and neck cancers and non-small lung cancer. The US FDA has...... hiện toàn bộ Nonsurgical Treatment of Recurrent Glioblastoma Tập 22 Số 4 - Trang 273-281
Óscar Gallego
Standard treatment for glioblastoma multiforme is surgery followed by radiotherapy and chemotherapy, generally with temozolomide. However, disease recurs in almost all patients. Diagnosis of progression is complex given the possibility of pseudoprogression. The Response Assessment in Neuro-Oncology criteria increase the sensitivity for detecting progression. Most patients will not be candi...... hiện toàn bộ Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain Metastases Tập 20 Số 4 - Trang 300-306
Arwa Ali, John R. Goffin, Andrew Arnold, Peter Ellis
Background: The prognosis of patients with brain metastases from non-small-cell lung cancer (NSCLC) is poor. However, some reports suggest that patients with brain metastases at the time of initial diagnosis have a more favourable survival than do patients with advanced NSCLC without brain metastases. Methods: In a retrospective cohort of all new lung cancer patients seen at a Canadian ter...... hiện toàn bộ Cancer and Venous Thromboembolic Disease: From Molecular Mechanisms to Clinical Management Tập 21 Số 3 - Trang 134-143
Eoin Donnellan, Barry Kevane, Brian Bird, Fionnuala Ní Áinle
Venous thromboembolism (VTE) represents a major challenge in the management of patients with cancer. The malignant phenotype is associated with derangements in the coagulation cascade that can manifest as thrombosis, hemorrhage, or disseminated intravascular coagulation. The risk of VTE is increased by a factor of approximately 6 in patients with cancer compared with non-cancer patients, a...... hiện toàn bộ A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Tập 26 Số 2 - Trang 4261
Kevin Li, Dean Giustini, Dugald Seely
Objectives: In cancer patients, chemotherapy-induced peripheral neuropathy (cipn) is a common complication, characterized by pain, loss of sensation, and numbness. Medical treatment for peripheral neuropathies has been shown to be ineffective for cipn. Acupuncture has been shown to be safe and effective in treating cancer-related symptoms and other peripheral neuropathies. For the present ...... hiện toàn bộ ALK Inhibitors, Resistance Development, Clinical Trials Tập 25 Số 11 - Trang 59-67
J. Rothenstein, Negar Chooback
The treatment of advanced non-small-cell lung cancer (NSCLC) has undergone a paradigm shift since the early 2000s. The identification of molecular subtypes of the disease, based on oncogenic drivers, has led to the development of personalized medicine and the ability to deliver molecularly targeted therapies to patients. In the 10 years that have elapsed since the discovery of the ALK gene...... hiện toàn bộ